Demand for implantable materials has shifted from simple defect filling toward precise biomechanical matching, according to the clinical rationale outlined in the company’s product materials. The portfolio is intended to give surgeons a systematic set of options across neurosurgery and spine surgery.

The lineup includes a dural substitute for neurosurgical reconstruction, bone-repair substitutes for orthopedic and dental applications, and spinal fixation devices such as zero-profile and expandable PLIF interbody cages, polyaxial pedicle screws and anterior cervical plates. Other offerings include minimally invasive surgical instruments, rapid molecular testing and complex trauma-repair solutions.

When selecting neurosurgical and spinal fixation materials, physicians must assess mechanical properties and tissue-integration capacity. Zero-profile and expandable PLIF interbody cages are designed to restore disc height through minimally invasive approaches while reducing disruption to surrounding soft tissue, the company’s materials state.

Bone-repair substitutes used in cranial defects or spinal fusion also require attention to particle morphology and bioactivity, because those characteristics can directly affect the rate of bone ingrowth. The company positions its bone-graft materials for matching to the anatomical and biological demands of a given defect.

For complex trauma-repair cases, clinical teams should match product specifications to imaging findings, including bone density and defect geometry, according to the company’s guidance. Minimally invasive instruments can shorten operating time, but they also place greater demands on procedural standardization.

Rapid molecular testing is described as an adjunct to preoperative assessment, not a replacement for standard diagnostic work. Its use is intended to refine perioperative management and support timely decisions when infection risk or pathological features are suspected.